MARSHALL WACE, LLP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$18,449,000
+530.7%
85,060
+256.9%
0.08%
+325.0%
Q2 2020$2,925,000
+540.0%
23,833
+357.2%
0.02%
+300.0%
Q1 2020$457,000
+47.9%
5,213
+76.4%
0.01%
+150.0%
Q4 2019$309,000
-94.5%
2,955
-93.9%
0.00%
-95.5%
Q3 2019$5,593,000
+382.6%
48,627
+623.7%
0.04%
+340.0%
Q2 2019$1,159,000
-71.0%
6,719
-71.7%
0.01%
-47.4%
Q1 2019$4,000,000
+854.7%
23,732
+452.2%
0.02%
+375.0%
Q4 2018$419,000
-97.2%
4,298
-97.5%
0.00%
-96.8%
Q2 2016$14,926,000
+2555.9%
170,500
+2008.3%
0.12%
+2400.0%
Q4 2015$562,0008,0870.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders